MMP and ADAM in rheumatoid arthritis

Connective Tissue

Volumn 36, Issue 4, 2004, Pages 223-231

  Yatabe, Taku ^a   Okada, Yasunori ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

A disintegrin and metalloproteinase; Extracellular matrix; Matrix metalloproteinase; Rheumatoid arthritis; Tissue inhibitor of metalloproteinases

Indexed keywords

MATRIX METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME;

ARTICULAR CARTILAGE; CARTILAGE DEGENERATION; ENZYME REGULATION; ENZYME SUBSTRATE; EXTRACELLULAR MATRIX; HUMAN; MULTIGENE FAMILY; NONHUMAN; PROLIFERATIVE SYNOVITIS; PROTEIN DEGRADATION; REVIEW; RHEUMATOID ARTHRITIS; SYNOVITIS;

EID: 11144297635     PISSN: 0916572X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (49)

1. Knauper, V., Lopez-Otin, C., Smith, B., Knight, G., and Murphy, G. (1996) Biochemical characterization of human collagenase-3. J. Biol. Chem. 271, 1544-1550
2. Knauper, V., Will, H., Lopez-Otin, C., Smith, B., Atkinson, S.J., Stanton, H., Hembry, R.M., and Murphy, G. (1996) Cellular mechanisms for human procollagenase-3 (MMP-13) activation. Evidence that MT1-MMP (MMP-14) and gelatinase a (MMP-2) are able to generate active enzyme. J. Biol. Chem. 271, 17124-17131
3. Okada, Y., Morodomi, T., Enghild, J.J., Suzuki, K., Yasui, A., Nakanishi, I., Salvesen, G., and Nagase, H. (1990) Matrix metalloproteinase 2 from human rheumatoid synovial fibroblasts. Purification and activation of the precursor and enzymic properties. Eur. J. Biochem. 194, 721-730
4. Okada, Y., Gonoji, Y., Naka, K., Tomita, K., Nakanishi, I., Iwata, K., Yamashita, K., and Hayakawa, T. (1992) Matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) from HT 1080 human fibrosarcoma cells. Purification and activation of the precursor and enzymic properties. J. Biol. Chem. 267, 21712-21719
5. Okada, Y., Nagase, H., and Harris, E.D., Jr. (1986) A metalloproteinase from human rheumatoid synovial fibroblasts that digests connective tissue matrix components. Purification and characterization. J. Biol. Chem. 261, 14245-14255
6. Nagase, H. (1997) Activation mechanisms of matrix metalloproteinases. Biol. Chem. 378, 151-160
7. Nakamura, H., Fujii, Y., Ohuchi, E., Yamamoto, E., and Okada, Y. (1998) Activation of the precursor of human stromelysin 2 and its interactions with other matrix metalloproteinases. Eur. J. Biochem. 253, 67-75
8. Imai, K., Yokohama, Y., Nakanishi, I., Ohuchi, E., Fujii, Y., Nakai, N., and Okada, Y. (1995) Matrix metalloproteinase 7 (matrilysin) from human rectal carcinoma cells. Activation of the precursor, interaction with other matrix metalloproteinases and enzymic properties. J. Biol. Chem. 270, 6691-6697
9. Park, H.I., Ni, J., Gerkema, F.E., Liu, D., Belozerov, V.E., and Sang, Q.X. (2000) Identification and characterization of human endometase (Matrix metalloproteinase-26) from endometrial tumor. J. Biol. Chem. 275, 20540-20544
10. Yana, I. and Seiki, M. (2002) MT-MMPs play pivotal roles in cancer dissemination. Clin. Exp. Metastasis. 19, 209-215
11. Ohuchi, E., Imai, K., Fujii, Y., Sato, H., Seiki, M., and Okada, Y. (1997) Membrane type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromoleclules. J. Biol. Chem. 272, 2446-2451
12. d'Ortho, M.P., Will, H., Atkinson, S., Butler, G., Messent, A., Gavrilovic, J., Smith, B., Timpl, R., Zardi, L., and Murphy, G. (1997) Membrane-type matrix metalloproteinases 1 and 2 exhibit broad-spectrum proteolytic capacities comparable to many matrix metalloproteinases. Eur. J. Biochem. 250, 751-757
13. Shimada, T., Nakamura, H., Ohuchi, E., Fujii, Y., Murakami, Y., Sato, H., Seiki, M., and Okada, Y. (1999) Characterization of a truncated recombinant form of human membrane type 3 matrix metalloproteinase. Eur. J. Biochem. 262, 907-914
14. Peschon, J.J., Slack, J.L., Reddy, P., Stocking, K.L., Sunnarborg, S.W., Lee, D.C., Russell, W.E., Castner, B.J., Johnson, R.S., Fitzner, J.N., Boyce, R.W., Nelson, N., Kozlosky, C.J., Wolfson, M.F., Rauch, C.T., Cerretti, D. P., Paxton, R.J., March, C.J., and Black, R.A. (1998) An essential role for ectodomain shedding in mammalian development. Science 282, 1281-1284
15. Sunnarborg, S.W., Hinkle, C.L., Stevenson, M., Russell, W.E., Raska, C.S., Peschon, J.J., Castner, B.J., Gerhart, M.J., Paxton, R.J., Black, R.A., and Lee, D.C. (2002) Tumor necrosis factor-alpha converting enzyme (TACE) regulates epidermal growth factor receptor ligand availability. J. Biol. Chem. 277, 12838-12845
16. Black, R.A. (2002) Tumor necrosis factor-alpha converting enzyme. Int. J. Biochem. Cell. Biol. 34, 1-5
17. Asakura, M., Kitakaze, M., Takashima, S., Liao, Y., Ishikura, F., Yoshinaka, T., Ohmoto, H., Node, K., Yoshino, K., Ishiguro, H., Asanuma, H., Sanada, S., Matsumura, Y., Takeda, H., Beppu, S., Tada, M., Hori, M., and Higashiyama, S. (2002) Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: metalloproteinase inhibitors as a new therapy. Nat. Med. 8, 35-40
18. Russell, D.L., Doyle, K.M., Ochsner, S.A., Sandy, J.D., and Richards, J.S. (2003) Processing and localization of ADAMTS-1 and proteolytic cleavage of versican during cumulus matrix expansion and ovulation. J. Biol. Chem. 278, 42330-42339
19. Somerville, R.P., Longpre, J.M., Jungers, K.A., Engle, J. M., Ross, M., Evanko, S., Wight, T.N., Leduc, R., and Apte, S.S. (2003) Characterization of ADAMTS-9 and ADAMTS-20 as a distinct ADAMTS subfamily related to Caenorhabditis elegans GON-1. J. Biol. Chem. 278, 9503-9513
20. Tortorella, M.D., Burn, T.C., Pratta, M.A., Abbaszade, I., Hollis, J.M., Liu, R., Rosenfeld, S.A., Copeland, R.A., Decicco, C.P., Wynn, R., Rockwell, A., Yang, F., Duke, J.L., Solomon, K., George, H., Bruckner, R., Nagase, H., Itoh, Y., Ellis, D.M., Ross, H., Wiswall, B.H., Murphy, K., Hillman, M.C., Jr., Hollis, G.F., and Arner, E.G. (1999) Purification and cloning of aggrecanase-1: a member of the ADAMTS family of proteins. Science 284, 1664-1666
21. Tortorella, M.D., Pratta, M., Liu, R.Q., Austin, J., Ross, O.H., Abbaszade, I., Burn, T., and Arner, E. (2000) Sites of aggrecan cleavage by recombinant human aggrecanase-1 (ADAMTS-4). J. Biol. Chem. 275, 18566-18573
22. Sandy, J.D., Westling, J., Kenagy, R.D., Iruela-Arispe, M. L., Verscharen, C., Rodriguez-Mazaneque, J.C., Zimmermann, D.R., Lemire, J.M., Fischer, J.W., Wight, T.N., and Clowes, A.W. (2001) Versican V1 proteolysis in human aorta in vivo occurs at the Glu441-Ala442 bond, a site that is cleaved by recombinant ADAMTS-1 and ADAMTS-4. J. Biol. Chem. 276, 13372-13378
23. Nakamura, H., Fujii, Y., Inoki, I., Sugimoto, K., Tanzawa, K., Matsuki, H., Miura, R., Yamaguchi, Y., and Okada, Y. (2000) Brevican is degraded by matrix metalloproteinases and aggrecanase-1 (ADAM TS4) at different sites. J. Biol. Chem. 275, 38885-38890
24. Okada, Y., Harris, E.D., Jr., and Nagase, H. (1988) The precursor of a metalloendopeptidase from human rheumatoid synovial fibroblasts. Purification and mechanisms of activation by endopeptidases and 4-aminophenylmercuric acetate. Biochem. J. 254, 731-741
25. Itoh, Y., Takamura, A., Ito, N., Maru, Y., Sato, H., Suenaga, N., Aoki, T., and Seiki, M. (2001) Homophilic complex formation of MT1-MMP facilitates proMMP-2 activation on the cell surface and promotes tumor cell invasion. Embo. J. 20, 4782-4793
26. Guo, H., Li, R., Zucker, S., and Toole, B.P. (2000) EMMPRIN (CD147), an inducer of matrix metalloproteinase synthesis, also binds interstitial collagenase to the tumor cell surface. Cancer Res. 60, 888-891
27. Puyraimond, A., Fridman, R., Lemesle, M., Arbeille, B., and Menashi, S. (2001) MMP-2 colocalizes with caveolae on the surface of endothelial cells. Exp. Cell. Res. 262, 28-36
28. Yu, W.H., Woessner, J.F., Jr., McNeish, J.D., and Stamenkovic, I. (2002) CD44 anchors the assembly of matrilysin/ MMP-7 with heparin-binding epidermal growth factor precursor and Erb B4 and regulates female reproductive organ remodeling. Genes. Dev. 16, 307-323
29. Yu, Q. and Stamenkovic, I. (2000) Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. Genes, Dev. 14, 163-176
30. Gomez, D.E., Alonso, D.F., Yoshiji, H., and Thorgeirsson, U.P. (1997) Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. Eur. J. Cell. Biol. 74, 111-122
31. Brew, K., Dinakarpandian, D., and Nagase, H. (2000) Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochim. Biophys. Acta 1477, 267-283
32. Baker, A.H., Edwards, D.R., and Murphy, G. (2002) Metalloproteinase inhibitors: biological actions and therapeutic opportunities. J. Cell Sci. 115, 3719-3727
33. Seiki, M. (2002) The cell surface: The stage for matrix metalloproteinase regulation of migration. Curr. Opin. Cell. Biol. 14, 624-632
34. Schlomann, U., Rathke-Hartlieb, S., Yamamoto, S., Jockusch, H., and Bartsch, J.W. (2000) Tumor necrosis factor alpha induces a metalloprotease- disintegrin, ADAM8 (CD156): Implications for neuron-glia interactions during neurodegeneration. J. Neurosci. 20, 7964-7971
35. Le Pabic, H., Bonnier, D., Wewer, U.M., Coutand, A., Musso, O., Baffet, G., Clement, B., and Theret, N. (2003) ADAM12 in human liver cancers: TGF-beta-regulated expression in stellate cells is associated with matrix remodeling. Hepatology 37, 1056-1066
36. Bzowska, M., Jura, N., Lassak, A., Black, R.A., and Bereta, J. (2004) Tumour necrosis factor-alpha stimulates expression of TNF-alpha converting enzyme in endothelial cells. Eur. J. Biochem. 271, 2808-2820
37. Yamanishi, Y., Boyle, D.L., Clark, M., Maki, R.A., Tortorella, M.D., Arner, E.G., and Firestein, G.S. (2002) Expression and regulation of aggrecanase in arthritis: The role of TGF-beta. J. Immunol. 168, 1405-1412
38. Mochizuki, S., Shimoda, M., Shiomi, T., Fujii, Y., and Okada, Y. (2004) ADAM28 is activated by MMP-7 (matrilysin-1) and cleaves insulin-like growth factor binding protein-3. Biochem. Biophys. Res. Commun. 315, 79-84
39. Hashimoto, G., Aoki, T., Nakamura, H., Tanzawa, K., and Okada, Y. (2001) Inhibition of ADAMTS4 (aggrecanase-1) by tissue inhibitors of metalloproteinases (TIMP-1, 2, 3 and 4). FEBS Lett. 494, 192-195
40. Hashimoto, G., Shimoda, M., and Okada, Y. (2004) ADAMTS4 (aggrecanase-1) interaction with the COOH-terminal domain of fibronectin inhibits proteolysis of aggrecan. J. Biol. Chem. 279, 32483-32491
41. Okada, Y., Takeuchi, N., Tomita, K., Nakanishi, I., and Nagase, H. (1989) Immunolocalization of matrix metalloproteinase 3 (stromelysin) in rheumatoid synovioblasts (B cells): correlation with rheumatoid arthritis. Ann. Rheum. Dis. 48, 645-653
42. Okada, Y., Gonoji, Y., Nakanishi, I., Nagase, H., and Hayakawa, T. (1990) Immunohistochemical demonstration of collagenase and tissue inhibitor of metalloproteinases (TIMP) in synovial lining cells of rheumatoid synovium. Virchows Arch. B Cell. Pathol. Incl. Mol. Pathol. 59, 305-312
43. Ahrens, D., Koch, A.E., Pope, R.M., Stein-Picarella, M., and Niedbala, M.J. (1996) Expression of matrix metalloproteinase 9 (96-kd gelatinase B) in human rheumatoid arthritis. Arthritis. Rheum. 39, 1576-1587
44. Yamanaka, H., Makino, K., Takizawa, M., Nakamura, H., Fujimoto, N., Moriya, H., Nemori, R., Sato, H., Seiki, M., and Okada, Y. (2000) Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in rheumatoid synovium. Lab. Invest. 80, 677-687
45. Takizawa, M., Ohuchi, E., Yamanaka, H., Nakamura, H., Ikeda, E., Ghosh, P., and Okada, Y. (2000) Production of tissue inhibitor of metalloproteinases 3 is selectively enhanced by calcium pentosan polysulfate in human rheumatoid synovial fibroblasts. Arthritis. Rheum. 43, 812-820
46. Yoshihara, Y., Nakamura, H., Obata, K., Yamada, H., Hayakawa, T., Fujikawa, K., and Okada, Y. (2000) Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids from patients with rheumatoid arthritis or osteoarthritis. Ann. Rheum. Dis. 59, 455-461
47. Böhm, B.B., Aigner, T., Blobel, C.P., Kalden, J.R., and Burkhardt, H. (2001) Highly enhanced expression of the disintegrin metalloproteinase MDC15 (metargidin) in rheumatoid synovial tissue. Arthritis. Rheum. 44, 2046-2054
48. Ohta, S., Harigai, M., Tanaka, M., Kawaguchi, Y., Sugiura, T., Takagi, K., Fukasawa, C., Hara, M., and Kamatani, N. (2001) Tumor necrosis factor-alpha (TNF-alpha) converting enzyme contributes to production of TNF-alpha in synovial tissues from patients with rheumatoid arthritis. J. Rheumatol. 28, 1756-1763
49. Horiuchi, K., Weskamp, G., Lum, L., Hammes, H.P., Cai, H., Brodie, T.A., Ludwig, T., Chiusaroli, R., Baron, R., Preissner, K.T., Manova, K., and Blobel, C.P. (2003) Potential role for ADAM15 in pathological neovascularization in mice. Mol. Cell Biol. 23, 5614-5624